Full Text
HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients

Abstract

Authors

F van Delft H Koffijberg M Schuurbiers H van Rossum M van den Heuvel M IJzerman

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×